Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Dec 1;178(6):2115-21.
doi: 10.1084/jem.178.6.2115.

Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction

Affiliations

Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction

B Nowicki et al. J Exp Med. .

Abstract

A bacterial pathogen that is important in both urinary tract and intestinal infections is Escherichia coli which expresses Dr or related adhesins. In this report, we present a model for testing cell-cell interaction, using both molecularly characterized laboratory cells that express recombinant molecules of human decay-accelerating factor (DAF), and recombinant bacterial Dr colonization factors. Dr adhesin ligand was identified as DAF (CD55), a membrane protein that protects autologous tissues from damage due to the complement system. Structure-function studies mapped the adhesin-binding site on the DAF molecule. A single-point substitution in the third short consensus repeat domain, Ser165 to Leu, corresponding to the Dra to Drb allelic polymorphism, caused complete abolition of adhesin binding to DAF.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunochemistry. 1969 May;6(3):391-403 - PubMed
    1. J Immunol. 1992 Nov 1;149(9):2906-13 - PubMed
    1. Infect Immun. 1980 Feb;27(2):569-75 - PubMed
    1. J Immunol. 1981 Nov;127(5):2035-9 - PubMed
    1. Lancet. 1981 Dec 19-26;2(8260-61):1366-9 - PubMed

Publication types